IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $962,593 | -46.6% | 211,559 | -17.4% | 0.00% | -40.0% |
| Q2 2023 | $1,802,655 | -20.5% | 256,059 | -31.0% | 0.01% | -28.6% |
| Q1 2023 | $2,267,170 | +34898.0% | 371,059 | -63.5% | 0.01% | -73.1% |
| Q4 2022 | $6,478 | -99.9% | 1,015,738 | +3.5% | 0.03% | -31.6% |
| Q3 2022 | $9,405,000 | -64.3% | 981,284 | -57.3% | 0.04% | -17.4% |
| Q2 2022 | $26,340,000 | +6831.6% | 2,298,802 | +19056.7% | 0.05% | +4500.0% |
| Q1 2021 | $380,000 | +38.2% | 12,000 | +20.0% | 0.00% | 0.0% |
| Q2 2020 | $275,000 | -69.1% | 10,000 | -89.1% | 0.00% | -75.0% |
| Q1 2019 | $891,000 | +65.6% | 91,392 | +50.1% | 0.00% | +100.0% |
| Q4 2018 | $538,000 | – | 60,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |